Conference Coverage (IBC)

(beta)-Lactam Combinations Have M. tb Killing Properties

Published in TB and Outbreaks Week, March 25th, 1996

Selected (beta)-lactams and (beta)-lactam-(beta)-lactamase inhibitor combinations have rapid bactericidal activity against Mycobacterium tuberculosis, according to a report from Nashville, Tennessee's Vanderbilt University.

The report was delivered at the IBC Biennial International Conference, "Mycobacterial Infection," held in Washington D.C. March 7-8, 1996.

Research presented in the 1940s confirmed that under certain culture conditions, penicillin inhibits the growth of Mycobacterium tuberculosis, but there has been little motivation to explore the potential utility of (beta)-lactams in the treatment of tuberculosis because effective...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1996-03-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry